Phase i dose-escalation study of procaspase-Activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas

Authors
Category Primary study
JournalNeuro-Oncology Advances
Year 2023
This article has no abstract
Epistemonikos ID: cd1f753b810f86685aa22787c52e80efbee66c30
First added on: Feb 16, 2025